United States · Series B startup

Who invested in Sopherion Therapeutics

2 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

HealthcareBiotech

Funding summaryUpdated 26 Oct 2026

$73Mraised across 2 rounds since 2003, from 2 sources

$26MSeries A$47MSeries B
Latest round
Series B, $47MSept 2004
Step-upi
1.8×
Investors
12
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2004
$26MSeries A$47MSeries B
First round
Series A, $26M
Mar 2003
Biggest round
$47M
Series B · Sept 2004
Between rounds
19 months
from the last two

The rounds

  1. Sept 2004
  2. Mar 2003

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

TL VenturesVC firm2rounds
ProQuest InvestmentsVC firm2rounds
HealthCapVC firm2rounds
Seaflower VenturesVC firm2rounds
CanaanVC firm1round
Connecticut InnovationsGovernment1round
Intersouth PartnersVC firm1round
Sprout GroupGrowth equity1round
NewSpring VenturesVC firm1round
Commerce Health CapitalInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Sopherion Therapeutics

Who invested in Sopherion Therapeutics?

Sopherion Therapeutics's investors include TL Ventures, ProQuest Investments, HealthCap, Seaflower Ventures and Canaan, and 7 more on record.

How much has Sopherion Therapeutics raised?

Sopherion Therapeutics has raised $73M across 2 rounds since 2003.

When did Sopherion Therapeutics last raise?

Sopherion Therapeutics's most recent round was a Series B of $47M in Sept 2004.

What was Sopherion Therapeutics's biggest round?

Its most recent round, $47M in Sept 2004, is also its largest on record.

Who backed Sopherion Therapeutics first?

Sopherion Therapeutics's first round on record, in Mar 2003, was backed by Connecticut Innovations, Intersouth Partners and Johnson & Johnson Development Corporation (JJDC) and 5 others.

What stage is Sopherion Therapeutics at?

Sopherion Therapeutics's latest named round is a Series B, in Sept 2004.

Where is Sopherion Therapeutics based?

Sopherion Therapeutics is based in the United States.

Companies like Sopherion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.